Big Pharma’s Unethical Game
We have all heard of lobbyists, both from “good” and “bad” organizations, companies and trade associations roaming through the halls of Congress and pretty much everywhere, trying to further their myriad economic, social and political agendas.
Those who still watch TV network news are very familiar with all kinds of erectile dysfunction drugs, arthritis, asthma, mental disorder, prostate, stomach, bladder, toe nail and other kinds of remedies offered by large pharmaceutical companies.
A lot of these drugs are found later to be downright deadly and pulled from the shelves, but until that time, they are perfectly able to bring billions to their manufacturers. After all, in most cases a huge part of the research leading to the development of many drugs is funded directly by government research grants and not really by the manufacturers, who have the gall of offering pills, costing them pennies for an often-exorbitant price. The Big Pharma excuses usually refer to “development costs”, indeed, those same costs, which you the taxpayer have already borne by paying for the research grants.
But lets not forget those expensive drug commercials during the network news, or multi-page ads in newspapers and magazines – those supremely annoying page-after-page ads, which contain warnings and disclaimers in fine print. Don’t be fooled for a minute that this information is meant as a “public service”. What it really amounts to is: “we warned you ahead of time, so if the drug damages your body, or kills you, you have been forewarned and shouldn’t sue us”.
This is not to say that all drugs are dangerous, or bad for you. There are some that actually help people, or cure them of all kinds of diseases. The lowly, inexpensive aspirin comes to mind, along with some antibiotics and some of the statin drugs (which should be used with care, in our opinion).
There is also no doubt that most drugs – at least those sold and pushed in the U.S. are way overpriced, others are way overused and others – at least according to Big Pharma-are actually underused.
That’s why you see so many of those drug ads and commercials and that is why that the big and even small pharmaceutical companies employ legions of sales representatives – not necessarily in the halls of Congress, but in physician’s offices, medical schools, publishing houses and everywhere their presence is deemed to be necessary for the financial well being of their companies.
How many of you have noticed the usually attractive, well-dressed women and men, towing roller cases through buildings housing “doctors’” offices? They seem to be ever-present. How about the reps bringing in catered lunches to the physician’s offices on a regular basis? Leaving tons of samples of their products, so the physicians can use them themselves, give them free of charge to their family members, or friends and to their patients?
Lets not be gullible and think that the samples and the lunches are given out of the goodness of the Big Pharma’s “hearts”. How about the exotic trips, golf vacations, dinners and gifts of all sorts?
Its is a nice, comfortable arrangement for many “doctors”, who in return for all of these favors often prescribe the drugs pushed by the reps, instead of treating their patients with the best (and often cheaper) of the available medicines.
At the same time, several university medical centers such as Yale have barred drug company sales reps from bringing free lunches to staff physicians. Yale might have been motivated to do so by the ‘C’ grade it received from the American Medical Student Association, a national group that rates how well medical schools monitor and control drug industry money.
We wonder if this trend will flourish and eventually bring about a ban throughout the medical industry. Frankly, we doubt it, as the whole shtick is much too comfy and profitable for all of the beneficiaries of such practices. This is corruption on a grand scale.
In the meantime, expect for the medical and drug expenses to continue climbing out of sight and to continue paying through the nose for health care, whether the Democrats manage to push the health care reform through, or not.














